Nevit Dilmen [creativecommons license] via Wikimedia Commons
Neurofibromatosis type 1 (NF1) is characterized by skeletal abnormalities such as scoliosis, fragility, fractures and pseudoarthrosis (failure of bones to fuse properly after fractures). The disorder is caused by mutations of neurofibromin, a protein that regulates cellular signaling pathways. New research from investigators at Vanderbilt University (Nashville, TN) suggests that treatment with the enzyme asfotase-α prevents skeletal defects in a mouse model of NF1 by increasing bone growth, mineralization and strength.
Lab Anim. (NY) 43, 338 (2014).
view full text (login required)